Search | Invivogen

ODN 2088 control - TLR9 Ligand

Negative control for ODN 2088

Dose-dependent inhibition of TLR9 activity in HEK-Blue™ mTLR9 cells.

#TLR7/8 Ligands

CL097 - TLR7/TLR8 Agonist

Imidazoquinoline compound - CAS #1026249-18-2

NF-κB response of HEK-Blue™-derived cells to CL097

NF-κB and IRF responses of THP1-Dual™-derived cells to CL097

#TLR7/8 Ligands

CL075 (3M002) - TLR7/TLR8 Agonist

Thiazoquinoline compound - CAS #256922-53-9

NF-κB response of HEK-Blue™-derived cells to CL075

NF-κB and IRF responses of HEK-Dual™-derived cells to CL075

ODN 1585 - TLR9 Agonist

Stimulatory CpG ODN, Class A, Mouse-preferred

Dose-dependent NF-κB response of ODN 1585 in HEK-Blue™ mTLR9 cells

NF-κB and IRF responses of ODN 1585 in THP1-Dual™ hTLR9 cells

ODN TTAGGG control - TLR9 Ligand

Negative control for ODN TTAGGG

Dose-dependent inhibition of TLR9 activity in HEK-Blue™ hTLR9 cells

ODN 1826 FITC - TLR9 Agonist

FITC-labeled CpG ODN, Class B, Mouse-preferred

Detection of ODN 1826 FITC

ODN 1826 Biotin - TLR9 Agonist

Biotin-labeled CpG ODN 1826, Class B, Mouse-preferred

Detection of ODN 1826 Biotin

ODN 2216 VacciGrade™ - TLR9-based Adjuvant

CpG ODN, Class A (Human) | Th1 response

Dose-dependent NF-κB response of ODN 2216 in HEK-Blue™ hTLR9 cells

Dose-dependent NF-κB and IRF responses in THP1-Dual™ hTLR9 cells

ODN 1826 VacciGrade™ - TLR9-based Adjuvant

CpG ODN, Class B (Mouse) | Th1 response

NF-κB response of ODN 1826 in HEK-Blue™-derived cells

NF-κB and IRF responses of ODN 1826 in THP1-Dual™ hTLR9 cells

Imiquimod VacciGrade™ (R837) - TLR7-based Adjuvant

Imidazoquinoline compound | Th1 response

NF-κB response of HEK-Blue™-derived cells to imiquimod

NF-κB and IRF responses of HEK-Dual™-derived cells to imiquimod

Recombinant human IFN-α10 protein - Bioactive cytokine

Recombinant cytokine, source: CHO cells

Human IFN-α10 SDS-PAGE analysis

Dose-response of HEK-Blue™ IFN-α/β cells to recombinant human IFN-α10

Human IL-12 & IL-23 p40 Antibody - Ustekinumab Biosimilar

Human IgG1 - CAS #815610-63-0

Dose-dependent inhibition of HEK-Blue™ IL-12 or HEK-Blue™ IL-23 response using Ustekinumab biosimilar

ODN 1826 control (ODN 2138) - TLR9 Ligand

Negative control for ODN 1826

Dose-dependent NF-κB response in HEK-Blue™ mTLR9 cells.

ODN 1826 - TLR9 Agonist

Stimulatory CpG ODN, Class B, Mouse-preferred

NF-κB response of ODN 1826 in HEK-Blue™-derived cells

NF-κB and IRF responses of ODN 1826 in THP1-Dual™ hTLR9 cells

ODN 1668 - TLR9 Agonist

CpG ODN, Class B (Mouse)

Dose-dependent NF-κB response of ODN 1668 in HEK-Blue™ mTLR9 cells

ODN 2006 control (ODN 2137) - TLR9 Ligand

Negative control for ODN 2006

Dose-dependent NF-κB response in HEK-Blue™ hTLR9 cells.

ODN 2006 (ODN 7909) - TLR9 Agonist

Stimulatory CpG ODN, Class B, Human-preferred

Species-driven TLR9 differential responses

NF-κB response induced by ODN 2006

IRF response induced by ODN 2006

Fc-hDectin-1a

Soluble human Dectin-1 receptor

Default product image

2'3'-cGAMP Control - STING Agonist Negative Control

2'3'-cGAMP negative control

2'3'-cGAMP-control chemical structure

ODN 2395 control - TLR9 Ligand

Negative control for ODN 2395, Class C, Human/mouse-preferred

NF-κB responses in HEK-Blue™ mTLR9 cells